Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.

This video shows a detailed painting process focused on creating realistic skin texture and natural-looking pores. Learn how layering, shading, and controlled brushwork can bring depth and lifelike ...

A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point to something “curative,” one expert said. By Gina Kolata In a small, ...

Doctors have been drilled for decades on the four big risks for heart disease, which kills more Americans every year than any other illness. The fearsome foursome: hypertension, smoking, high levels ...

Despite guideline recommendations, evidence from randomized trials evaluating the appropriate low-density lipoprotein (LDL) cholesterol target for secondary prevention in patients with atherosclerotic ...

Without better prevention and early detection, the number of women living with cardiovascular disease will increase substantially in the coming decades, the American Heart Association said Wednesday.

An Oregon State University scientist and a team of undergraduate students have uncovered real-time insights into a chemical process linked with Alzheimer's disease, paving the way toward better drug ...

Please provide your email address to receive an email when new articles are posted on . The pathway aims to streamline approval for individualized treatments for rare and ultra-rare diseases. An ...

Wegovy (semaglutide) is part of a class of drugs called GLP-1 receptor agonists. These drugs control your blood sugar by mimicking the hormone glucagon-like peptide-1 (GLP-1). This hormone, found ...

For decades, businesses have been trapped in a cycle of painful, episodic change, launching massive re-engineering projects and investing in new IT systems, only to find their organization’s ...

Deaths from both causes are down, but they still eclipse all other causes, according to new statistics. By Nina Agrawal Despite gains in treatment, cardiovascular disease remains the leading cause of ...